Key statistics
As of last trade, Lifeward Ltd (LFWD:NAQ) traded at 7.09, 71.23% above the 52 week low of 4.14 set on Feb 24, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 6.48 |
|---|---|
| High | 7.09 |
| Low | 6.88 |
| Bid | 6.95 |
| Offer | 7.11 |
| Previous close | 7.40 |
| Average volume | 55.10k |
|---|---|
| Shares outstanding | 1.52m |
| Free float | 1.50m |
| P/E (TTM) | -- |
| Market cap | 11.28m USD |
| EPS (TTM) | -35.73 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 14:35 GMT.
More ▼
- Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
- Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors
- Lifeward Announces Reverse Share Split
- Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
- Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
- Lifeward Appoints Bob Marshall as Chairman of the Board
- Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
- Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
- UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton
- Lifeward Ltd. Reports Third Quarter 2025 Financial Results
More ▼
